Lifshitz & Miller Law Firm Announces Investigation of Annie's, Inc., Montage Technology Group Limited, OpenTable, Inc., Provectus Biopharmaceuticals, Inc., and The Bancorp Inc.

NEW YORK, June 14, 2014 /PRNewswire/ -- Annie's, Inc. Lifshitz & Miller announces that a class action was filed in the United States District Court for the Northern District of California alleging Annie's, Inc. (BNNY) and certain of its officers and directors issued false and misleading statements between August 8, 2013 and June 3, 2014. Specifically, the complaint alleges that: (1) the historical methodology for estimating certain trade allowances was not designed to include all related trade promotion costs subsequent to period end; and (2) the controls over accounting for contract manufacturing were not designed to precisely evaluate the valuation and accuracy of all contract manufacturing receivables and payables.

For information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at [phone] or by sending an e-mail including your contact information to: [e-mail].

Montage Technology Group Limited

Lifshitz & Miller announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Montage Technology Group Limited (MONT) to Shanghai Pudong Science and Technology Investment Co., Ltd. in a cash transaction valued at $22.60 per Ordinary Share or approximately $693 million, on a fully diluted basis.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at [phone] or by sending an e-mail including your contact information to: [e-mail].

OpenTable, Inc.

Lifshitz & Miller announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of OpenTable, Inc. (OPEN) to The Priceline Group Inc. in a cash transaction valued at $103 per share or approximately $2.6 billion.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at [phone] or by sending an e-mail including your contact information to: [e-mail].

Provectus Biopharmaceuticals, Inc.

Lifshitz & Miller announces that a class action was filed in the United States District Court for the Middle District of Tennessee alleging that Provectus Biopharmaceuticals, Inc. ("PVCT") issued false and misleading statements. Specifically, defendants made false and/or misleading statements and/or failed to disclose that as early, as the beginning of 2014, the company overstated the potential for success of PV-10 while Provectus was simultaneously engaged in improper stock promotion activities.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at [phone] or by sending an e-mail including your contact information to: [e-mail].

The Bancorp Inc.

Lifshitz & Miller announces an investigation into possible claims against the board of directors of The Bancorp Inc. (TBBK). Specifically, the Company announced on June 10, 2014 that its wholly owned subsidiary entered into a Stipulation and Consent to the Issuance of a Consent Order with the Federal Deposit Insurance Corporation which became effective on June 5, 2014 in connection with charges of unsafe or unsound banking practices or violations of law or regulation relating to weaknesses in the Bank's Bank Secrecy Act Compliance Program.

For information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at [phone] or by sending an e-mail including your contact information to: [e-mail].

ATTORNEY ADVERTISING. © 2014 Lifshitz & Miller. The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: [phone]. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone: [phone]
Facsimile: 516-280-7376
Email: [e-mail]

SOURCE Lifshitz & Miller Law Firm